Literature DB >> 8994866

B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men.

K B Elkon1, A Marshak-Rothstein.   

Abstract

In mice functionally deficient for either Fas or Fas ligand expression, the failure of Fas-ligand-expressing cytotoxic T cells to eliminate autoreactive B cells can result in excessive autoantibody production. Recent in vitro studies have shown that B cells activated by CD40 ligand become extremely sensitive to Fas-mediated apoptosis while IL-4 and/or surface IgM receptor engagement protects B cells from Fas ligand cytolysis. Potential in vivo sites for Fas ligand regulation of self-reactive B cells have been suggested and implications for human disease have been investigated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8994866     DOI: 10.1016/s0952-7915(96)80015-x

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  10 in total

1.  Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

Authors:  M Boes; T Schmidt; K Linkemann; B C Beaudette; A Marshak-Rothstein; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Influence of Fas on the regulation of the response of an anti-nuclear antigen B cell clonotype to foreign antigen.

Authors:  Boris Alabyev; Raja Vuyyuru; Tim Manser
Journal:  Int Immunol       Date:  2008-08-08       Impact factor: 4.823

Review 3.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 4.  Molecular mechanism of immune response, synovial proliferation and apoptosis in rheumatoid arthritis.

Authors:  T Hasunuma; T Kato; T Kobata; K Nishioka
Journal:  Springer Semin Immunopathol       Date:  1998

5.  FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigen.

Authors:  Attila Végh; Judit Cervenak; István Jankovics; Imre Kacskovics
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

6.  Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung.

Authors:  Y Peng; J Trevejo; J Zhou; M W Marino; R G Crystal; E Falck-Pedersen; K B Elkon
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  FAS mRNA editing in Human Systemic Lupus Erythematosus.

Authors:  Jianming Wu; Fenglong Xie; Kun Qian; Andrew W Gibson; Jeffrey C Edberg; Robert P Kimberly
Journal:  Hum Mutat       Date:  2011-08-11       Impact factor: 4.878

8.  Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.

Authors:  Jianming Wu; Maureen H Richards; Jinhai Huang; Lena Al-Harthi; Xiulong Xu; Rui Lin; Fenglong Xie; Andrew W Gibson; Jeffrey C Edberg; Robert P Kimberly
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

9.  Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies.

Authors:  T L O'Keefe; G T Williams; F D Batista; M S Neuberger
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

10.  Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice.

Authors:  Norihiko Watanabe; Koichi Ikuta; Sazuku Nisitani; Tsutomu Chiba; Tasuku Honjo
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.